glp-1 weight loss effects Part 1 of a 3-Part Series; Medications for Nutritional priorities to support GLP-1

Description

Limited insurance coverage and recent shortages only complicate access

Ozempic Gasteroparesis Risk Concealed By Novo Nordisk Through Misleading Marketing: Lawsuit Pennsylvania woman was taken off of the Ozempic injections after her stomach pains and constant vomiting symptoms were linked to gastroparesis, also known as stomach paralysis

Although epiploic appendagitis has not been identified as a safety signal in randomized trials, systematic reviews, or pharmacovigilance analyses of GLP-1/GIP receptor agonists, this case highlights epiploic appendagitis as an important diagnostic consideration in patients presenting with focal abdominal pain during periods of substantial weight loss

They talked, among other things, about the impact of cutting thousands of jobs at federal health agencies and the high cost of some of the most popular prescription drugs